Low-dose oral contraceptive effects on thromboelastogram criteria and relationship to hypercoagulability

American Journal of Obstetrics and Gynecology

Volumn 189, Issue 1, 2003, Pages 43-47

  Zahn, Christopher M ^a   Gonzalez, Dagoberto I ^a   Suto, Cathleen ^a   Kennedy, Sara ^a   Hines, Jeffrey F ^a  

^a WILFORD HALL MEDICAL CENTER   (United States)

Author keywords

Hypercoagulability; Low dose oral contraceptives; Thromboelastography

Indexed keywords

ETHINYLESTRADIOL; ETHINYLESTRADIOL PLUS LEVONORGESTREL; ETHINYLESTRADIOL PLUS NORGESTIMATE; GESTAGEN; LEVONORGESTREL; NORGESTIMATE; NORGESTREL; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; HYPERCOAGULABILITY; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MENSTRUATION DISORDER; METRORRHAGIA; NAUSEA; ORAL CONTRACEPTION; PRIORITY JOURNAL; THROMBOELASTOGRAPHY; THROMBOEMBOLISM;

EID: 0037998709     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2003.344     Document Type: Article

References (25)

1. Mammen EF. Oral contraceptives and blood coagulation: a critical review. Am J Obstet Gynecol 1982;142:781-90.
2. Notelovitz M, Kitchens CS, Coone L, McKenzie L, Carter R. Low-dose oral contraceptive usage and coagulation. Am J Obstet Gynecol 1981;141:71-5.
3. Winkler UH. Blood coagulation and contraceptives: a critical review. Contraception 1998;57:211-30.
4. Mallett SV, Cox JA. Thromboelastography. Br J Anaesth 1992;69:307-13.
5. Hartert HH. Blutgerninnungstudien mit der Thromboelastographie, einem neuen Untersuchungsverfahren. Klin Wochenschr 1948;26:577-83.
6. Lorrain J, Harel P. Effects of certain contraceptive hormones on blood coagulation. Fertil Steril 1972;23:422-7.
7. Poller L, Thomson JM, Thomas W. Oestrogen/progestogen oral contraception and blood clotting: a long-term follow-up. BMJ 1971;4:648-50.
8. von Kaulla E, Droegmneller W, von Kaulla KN. Conjugated estrogens and hypercoagulability. Am J Obstet Gynecol 1975;122:688-92.
9. Mink IB, Courey NG, Niswander KR, Moore RH, Lillie MA, Ambrus JL. Progestational agents and blood coagulation, V: changes induced by sequential oral contraceptive therapy. Am J Obstet Gynecol 1974;119:401-5.
10. Siro B, Misz M, Bazso J. Thromboelastograph studies in oral contraception. Am J Obstet Gynecol 1973;116:1167-8.
11. Fisch IR, Freedman SH. Oral contraceptives, ABO blood groups, and in vitro fibrin formation. Obstet Gynecol 1975;46:473-9.
12. Traverso CI, Caprini JA, Arcelus JI. The normal thromboelastogram and its interpretation. Semin Thromb Hemostas 1995;21 (4 Suppl):7-13.
13. Arcelus JI, Traverso CI, Caprini JA. Thromboelastography for the assessment of hypercoagulability during general surgery. Semin Thromb Hemostas 1995;21(4 Suppl):21-6.
14. Zuckerman L, Cohen E, Vagher JP, Woodward E, Caprini JA. Comparison of thromboelastography with common coagulation tests. Thromb Haemost 1981;46:752-6.
15. Traverso CI, Arcelus JI, Gomez E, Luna JD, Lopez-Cantarero M, Garcia JM. Prospective assessment of the risk of deep venous thrombosis in elective abdominal surgery: predictive role of thromboetastography. Thromb Haemorrh Disord 1993;7:9-15.
16. Zyranov BN, Tutrin II, Udut VV. Risk evaluation of thromboembotic diseases according to functional test data in patients with advanced malignancies. Neoplasma 1987;34:353-60.
17. Poller L, Thomson JM, Thomas W, Wray C. Blood clotting and platelet aggregation during oral progestogen contraception: a follow-up study. BMJ 1971;1:705-7.
18. Carr BR. Uniqueness of oral contraceptive progestins. Contraception 1998;58(3 Suppl):23S-7S.
19. Fotherby K. Pharmacokinetics and metabolism of progestins. In: Goldzieher JW, Fotherby K, editors. Pharmacology of the contraceptive steroids. NewYork: Raven Press; 1994. p. 99-126.
20. Lewis MA, Heinemann LA, MacRae KD, Bruppacher R, Spitzer WO. The increased risk of venous thromboembolism and the use of third generation progestagens: role of bias in observational research. The Transnational Research Group on Oral Contraceptives and the Health of Young Women. Contraception 1996;54:5-13.
21. Carr BR, Ory H. Estrogen and progestin components of oral contraceptives: relationship to vascular disease. Contraception 1997;55:267-72.
22. Lidegaard O, Edstrom B, Kreiner S. Oral contraceptives and venous thromboembolism: a case control study. Contraception 1998;57:291-301.
23. Beller FK, Ebert C. Effects of oral contraceptives in blood coagulation: a review. Obstet Gynecol Surv 1985;40:425-36.
24. Jick H, Jick SS, Gurewich V, Myers MW, Vasilakis C. Risks of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagens components. Lancet 1995;346:1589-93.
25. Farley TM, Collins J, Schlesselman JJ. Hormonal contraception and risk of cardiovascular disease: an international perspective. Contraception 1998;57:211-30.